The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Janssen-Cilag (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Roche
IFCT-1001 CHIVA trial: A phase II study of carboplatin (Ca) plus pemetrexed (P) followed by P maintenance, as first-line therapy for human immunodeficiency virus (HIV)–associated advanced non-squamous non-small cell lung cancer (NS-NSCLC).
 
Armelle Lavole
No Relationships to Disclose
 
Pascale Tomasini
No Relationships to Disclose
 
Isabelle Monnet
No Relationships to Disclose
 
Lize Kiakouama-Maleka
No Relationships to Disclose
 
Xavier Quantin
No Relationships to Disclose
 
Laurent Taillade
No Relationships to Disclose
 
Hervé Lena
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Boehringer Ingelheim; Lilly; Roche/Genentech
 
Philippe Fraisse
No Relationships to Disclose
 
Henri Janicot
No Relationships to Disclose
 
Clarisse Audigier-Valette
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche; Sysmex
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Roche; Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
 
Alain Makinson
No Relationships to Disclose
 
Alexandra Langlais
No Relationships to Disclose
 
Marie Paule Lebitasy
No Relationships to Disclose
 
Franck Morin
No Relationships to Disclose
 
Jacques Cadranel
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche